Allergy, Asthma, and Atopic Eczema in Finland
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorTampere University
About this trial
The summary is available at --\> https://www.finnatopy.fi/summary
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
https://www.finnatopy.fi/methods
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
No intervention
Other interventionNo intervention
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Epidemiology of atopic diseases and allergic sensitization profiles in Finland
Incidence and prevalence of asthma, specific IgE sensitization, atopic dermatitis, allergic rhinitis
Time frame
7 years2
Burden of atopic diseases (allergies, asthma, and atopic eczema) as well as comorbidities in Finland
Morbidity, sick leaves, medication use, costs and expences
Time frame
7 years3
Evaluate and improve the current use of diagnostic tests for atopic diseases
Diagnostic practices, tests for allergic sensitization, lung function tests, and other laboratory measures.
Time frame
7 years4
Use and effectiveness of allergen immunotherapy in real world setting
Real world evidence data using specific cohorts
Time frame
7 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Tampere University
Lead sponsor
Professor Lauri Lehtimäki
Collaborator
Professor Mika Mäkelä
Collaborator
Professor Sanna Toppila-Salmi
Collaborator
Professor Ilkka Junttila
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: